A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

Authors :: O'Neil BH
Scott AJ
Ma WW
Cohen SJ
Aisner DL
Menter AR
Tejani MA
Cho JK
Granfortuna J
Coveler AL
Olowokure OO
Baranda JC
Cusnir M
Phillip P
Boles J
Nazemzadeh R
Rarick M
Cohen DJ
Radford J
Fehrenbacher L
Bajaj R
Bathini V
Fanta P
Berlin J
McRee AJ
Maguire R
Wilhelm F
Maniar M
Jimeno A
Gomes CL
Messersmith WA
Source :: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 Jun; Vol. 27 (6), pp. 1180. Date of Electronic Publication: 2016 Mar 03.
Publication Year :: 2016

Language :: English
ISSN :: 1569-8041
Volume :: 27
Issue :: 6
Database :: MEDLINE
Journal :: Annals of oncology : official journal of the European Society for Medical Oncology
Publication Type :: Academic Journal
Accession number :: 26945010
Full Text :: https://doi.org/10.1093/annonc/mdw095

Full Text Access

Tools